Naperville, IL -- (ReleaseWire) -- 06/16/2014 -- Reportstack, provider of premium market research reports announces the addition of Botswana Pharmaceuticals and Healthcare Report Q3 2014 market report to its offering
We remain relatively optimistic over the growth potential of Botswana's pharmaceutical and
healthcare sector, given the government's aim to improve healthcare. However, implementation of these
healthcare aims remain a risk, as issues such as counterfeit pharmaceuticalsand expired products
highlights issues in drug procurement, thereby limiting healthcare access.
While Botswana offers a relatively stable environment for pharmaceutical and healthcare investors, low percapita
pharmaceutical and healthcare expenditure will remain a key downside risk to the development of the
sector. In addition, the overall Sub-Saharan Africa region has low expenditure on healthcare and
pharmaceutical, making it less likely that firms will invest in the region.
Headline Expenditure Projections
Pharmaceuticals: BWP1.60bn (USD193mn) in 2013 to BWP1.74bn (USD201mn) in 2014; +7.2% in local
currency terms and 4.0% in US dollar terms. Forecast broadly in line with Q214.
To view the table of contents for this market research report please visit